chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Onset of PMR symptoms about four weeks after shot. Muscular aches in shoulders, hips, thighs.  Progressively worse daily, until extreme pain in AM became debilitating.  Diagnosed with PMR on May 27 by Primary care doctor. Started 10mg. prednisone. Symptoms subsided.  August 5 prescribed 5mg. prednisone.
Taken all five Pfizer shots for COVID, still got COVID; Taken all five Pfizer shots for COVID, still got COVID; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the patient.  A patient (no qualifiers provided) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose 1, single (Batch/Lot number: unknown), as dose 2, single (Batch/Lot number: unknown), as dose 3 (booster), single (Batch/Lot number: unknown), as dose 4 (booster), single (Batch/Lot number: unknown) and as dose 5 (booster), single (Batch/Lot number: unknown) for COVID-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "Taken all five Pfizer shots for COVID, still got COVID". Additional information: The patient was in pain and disappointed.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
No adverse event. Patient received the Pfizer BioNtech 5-11 yrs Covid vaccine formulation, resulting in a lower-than-authorized dose.
Patient reported that left arm sore last eve but thought it was from the tetanus. Around 10:00pm 11/7 after returning home from school, noted left arm redness in mirror. This AM came to health department, red area indurated 55cm. Received Motrin and cold compresses.
Arm soreness; A spontaneous report was received from other health professional concerning a 51-year-old, female consumer who received Moderna's COVID-19 vaccine and developed soreness in her arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 04 Jan 2021 at 07:15AM, prior to the onset of the events, the patient received their first of two doses of mRNA-1273 (Lot number: unknown) intramuscularly for prophylaxis of COVID-19 infection.     On 04 Jan 2021, after receiving her vaccination, the patient began to develop soreness on her left arm. Treatment for the event included ice massage on her arm.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome for the events, soreness in her arm, was unknown.   The reporter's assessment of causality for the event was not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Abdomoinal Pain, Nausea and vomiting, body aches and fatigue.
Breakthrough case admission after 3 vaccines Pfizer 3/20/21 lot# EN6202;  Pfizer 4/13/21 lot# ER873;  Pfizer 12/4/21 lot# 59267100001
11:20am 5/13 Received vaccination. 1:22am 5/14 Intense pain and uncontrollable chills. 1:30am 5/14 400mg of Ibuprofen taken. 1:50am 5/14 Chills subside, muscle pain continues. 8:30am 5/14 Muscle soreness in cervical spine, lumbar spine, and thighs. 100.1°F fever. 10:30am 5/14 Intense back and spinal pain and chills. No fever. 11:30am 5/14 500mg of Acetaminophen taken. 12:30pm 5/14 Chills subside. Sore back for rest of day.
Red, swollen, extremely sore at the injection site after both shots One day following both vaccinations, I experienced exhaustion, body aches, and slight fever.  As a result of these side effects, I missed a total of 3 days of work.
Patient received the 2nd Hepatitis B dose 7 days too soon from the scheduled date. Patient denied adverse symptoms, she was told to come back at the 28th day from first dose to repeat the second dose.
COVID arm; Rash in the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (COVID arm) and VACCINATION SITE RASH (Rash in the injection site) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE REACTION (COVID arm) and VACCINATION SITE RASH (Rash in the injection site). At the time of the report, VACCINATION SITE REACTION (COVID arm) and VACCINATION SITE RASH (Rash in the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications provided. No treatment medications provided.   This case was linked to MOD-2021-349571 (Patient Link).
Subjective fever, chills, arthralgias, headache, nausea. Swelling and pain at injection site
Lymph node swollen, near right collarbone, after second vaccine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 13Jul2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), administration date: 15Jun2021, for COVID-19 immunisation. The following information was reported: LYMPHADENOPATHY (non-serious), outcome "unknown", described as "Lymph node swollen, near right collarbone, after second vaccine".  No follow-up attempts are possible. No further information is expected.
Information has been received from a physician concerning a patient who was vaccinated with a dose of Pneumovax 23. Subsequently the patient developed pain, large swelling and redness at the injection site. The patient went to the emergency room and was treated with unspecified steroids. Subsequently, the patient recovered. The reporting physician considered pain, large swelling and redness at the injection site to be other important medical events. Additional information has been requested.
shingles; Information has been received from a lawyer and a patient of unknown age and gender regarding a case in litigation. Information about concurrent condition, medical history and concomitant medication was not reported. On or about 07-OCT-2015, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (strength, dose, lot# and route unknown) for the long-term prevention of shingles and zoster-related conditions. Subsequent to the inoculation (date not reported), the patient was treated by a health care provider for shingles. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient has and will continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs include care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffer such losses, and damages in the future. The outcome of the event shingles was not recovered. The causality assessment was considered as related by the lawyer.
Inflammation on legs; Raised small bumps and patchy spots on hands; itching, redness, burning feet; itching, redness, burning feet; itching, redness, burning feet; Fever; Joint pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of INFLAMMATION (Inflammation on legs), RASH (Raised small bumps and patchy spots on hands), PRURITUS (itching, redness, burning feet), ERYTHEMA (itching, redness, burning feet) and BURNING SENSATION (itching, redness, burning feet) in a 23-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026Z21A and 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history was provided.).   On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 09-Apr-2021, the patient experienced INFLAMMATION (Inflammation on legs), RASH (Raised small bumps and patchy spots on hands), PRURITUS (itching, redness, burning feet), ERYTHEMA (itching, redness, burning feet), BURNING SENSATION (itching, redness, burning feet), PYREXIA (Fever), ARTHRALGIA (Joint pain) and HEADACHE (Headache). On 11-Apr-2021, PYREXIA (Fever) outcome was unknown. On 14-Apr-2021, HEADACHE (Headache) outcome was unknown. At the time of the report, INFLAMMATION (Inflammation on legs), RASH (Raised small bumps and patchy spots on hands), PRURITUS (itching, redness, burning feet), ERYTHEMA (itching, redness, burning feet), BURNING SENSATION (itching, redness, burning feet) and ARTHRALGIA (Joint pain) outcome was unknown. Not Provided          No concomitant medications were reported. Patient reported taking two doses of acetaminophen (Tylenol) for two days to treat events and reported that she will be contacting her health care provider to discuss the symptoms and further treatment options.
The patient states she asked for a COVID-19 vaccine but erroneously received a FLUAD Quad vaccine. No adverse effects. Error was discovered when the patient sought out her annual Flu vaccine.
pt recvd vax 3SEP92 & had rash on neck/chest/stomach/arms/legs, fatigue, conjuncctivitis; seen by MD; was not treated; sx persist;
Patient notified pharmacy on 2/9/16. Experienced enlarged and painful lymph nodes under armpits. MD was notified and informed patient that side effect is possible. Patient did not receive treatment and symptoms resolved after 2 weeks.
Patient recieved DTAP in left thigh on 03/21/2005.  On 03/23/2005 mom states childs left leg is swollen from the injection site down to the knee. she states the knee is also swollen.
Pt. had a chief complaint of throat swelling and difficulty swallowing.  Pt. states that he was walking to his car after his thirty minutes was up and started to feel the reaction.  After Pt. came back in he was instructed to sit down, and it was determined that Pt. throat was swelling. Pt. took 50mg of his own benadryl orally. Pt states the benadryl is not helping and its getting increasingly difficult to swallow. Pt. was brought into the back room where he walked without difficulty.  Pt. was given 0.3 of Epi in his left arm.  Pt. stated that his throat was starting to improve five minutes after injection.  Pt. care was transferred to Ambulance without incident.
Information has been received from a licensed practical nurse concerning a 2 year old female who on 02/08/02 was vaccinated with a dose of rubella virus vaccine (second generation). On 02/11/2002, it was reported that the patient "has not slept since." The patient sought unspecified medical attention. Additional information has been requested.
Patient has developed a loud vocal tic since getting her booster. She inhales quickly and loudly. It?s making her very self conscious and she is scared more will develop.
PATIENT HAD BEEN ON CHAIR MONITORING FOR 14 MINUTES WHEN SHE FAINTED.  NOT CERTAIN IF SHE HAD A SEIZURE. HOSPITAL WAS CALLED TO THE SCENE AND SHE WAS TRANSFERRED TO HOSPITAL FOR OBSERVATION. PHARMACIST SPOKE TO PATIENT'S MOM THIRTY MINUTES LATER AND SHE WAS ENROUTE. MOM STATED SHE WAS DOING OKAY.
CHILLS, BODY ACHES, HEADACHE,NAUSEA, FEVER, AND MILD CHEST PAINS.  NO TREATMENT OR DR. VISIT.
4/25/06, seen by doctor for increased fever and itchy rash on face, neck, back and chest, spreading; excoriated with some vesicles. Diagnosed with chickenpox. Treatment: Zovirax and Benadryl.
pt ran t102 18MAE95; mom reports she gave pt APAP q 4hrs from the time the vax were administered; t105-cough; mom called ER but was not seen; advised cool bath to reduce fever;
Pt given Anthrax vaccine #1 not knowing she was 7 wks pregnant at time of vaccine.
At  the time of the vaccination, I could feel it pooling in my arm, and I could feel a burning sensation (and it burnt as it spread). Within 30 minutes  I got dizzy, but this only lasted a few seconds. Within an hour, I felt like I was going to vomit and have diarrhea (this was not severe). Within two hours I was weak, my arm was getting sore and stiff, and I started shivering. Within seven hours, I felt like I had the flu. During the night I got extremely sick, extreme soreness of arm, headaches, muscle aches, fever, severe joint pain, pain extending into eye sockets, and slight swelling of throat.
metallic taste in mouth; This spontaneous case was reported by a consumer and describes the occurrence of DYSGEUSIA (metallic taste in mouth) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DYSGEUSIA (metallic taste in mouth). At the time of the report, DYSGEUSIA (metallic taste in mouth) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Red itchy spot 2 inches in diameter appeared  12 days after the shot, directly at the spot where it was given
she has a rash of bumps on her left arm around where the shot was given.; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (she has a rash of bumps on her left arm around where the shot was given.) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Aug-2021, the patient experienced VACCINATION SITE RASH (she has a rash of bumps on her left arm around where the shot was given.). At the time of the report, VACCINATION SITE RASH (she has a rash of bumps on her left arm around where the shot was given.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were reported. No Treatment medication was provided.
A painless rash/ distorted skin color on the left arm between the writer & elbow. No itch & no bumps. Noticed around 3:45 pm on 2/24/21.
3-4 weeks after receiving TDAP, developed numb feeling in feet and hands. Had difficulty walking - used a cane. Admitted to hospital 7/5/11. Received IV immune globulin.
Pt experienced swelling and pain in right neck/shoulder area of arm where vax was administered.
spider bite-like spots/rash on her back, arms and legs that was itching, red, and swollen; runny nose; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (spider bite-like spots/rash on her back, arms and legs that was itching, red, and swollen) and RHINORRHOEA (runny nose) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, the patient experienced RASH ERYTHEMATOUS (spider bite-like spots/rash on her back, arms and legs that was itching, red, and swollen) and RHINORRHOEA (runny nose). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, RASH ERYTHEMATOUS (spider bite-like spots/rash on her back, arms and legs that was itching, red, and swollen) and RHINORRHOEA (runny nose) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided.
Patient describes sharp pains at vaccine admin site - has persisted for approx 2 wks.
Extreme upset stomach, diarrhea, extreme sweating, nausea, weakness, headache, fatigue, lasted 48 hours. This drug should not be on the market.
Flu vaccine given - immediate soreness at delt inj site followed by pain in ipsilateral axilla and swelling. Swelling gone now constant sting/throb in axilla persist.
Patient's left arm had a hard knot and red  golf ball size area around 5pm the night of getting the vaccine. It was hard to the touch, redness, swelling, itching. By the weekend (2/28) the red area doubled in size. There is still a hard knot where she received the vaccine. She is currently still experiencing the symptoms.
sweat all day; felt just really bad; just felt unwell; Headache; Diarrhea; Muscle pain; Chills; have been pretty tired too and do have fatigue, lack of energy; Fever; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient. A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), on 18Sep2023 as dose 1, single (Lot number: HH7595) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary immunization series completed; Manufacturer Unknown), for covid-19 immunization. The following information was reported: CHILLS (non-serious) with onset 30Sep2023, outcome "unknown"; DIARRHOEA (non-serious) with onset 30Sep2023, outcome "unknown", described as "Diarrhea"; PYREXIA (non-serious) with onset 30Sep2023, outcome "unknown", described as "Fever"; HEADACHE (non-serious) with onset 30Sep2023, outcome "unknown"; MYALGIA (non-serious) with onset 30Sep2023, outcome "unknown", described as "Muscle pain"; FEELING ABNORMAL (non-serious) with onset 30Sep2023, outcome "unknown", described as "felt just really bad"; FATIGUE (non-serious) with onset 30Sep2023, outcome "unknown", described as "have been pretty tired too and do have fatigue, lack of energy"; MALAISE (non-serious) with onset 30Sep2023, outcome "unknown", described as "just felt unwell"; HYPERHIDROSIS (non-serious) with onset 30Sep2023, outcome "unknown", described as "sweat all day". Relevant laboratory tests and procedures are available in the appropriate section. Clinical course details: The patient that the patient received the updated booster Pfizer Covid vaccine on 18Sep2023 and was going really well. The patient didn't have any issues until this morning when the patient was sweating and felt just really bad. The patient also had headache, diarrhea and muscle pain, then it is when the patient finally got chills. The patient basically sweat all day and was in the rest room between the restroom then on the bed all day. The patient have been pretty tired too and do have fatigue, lack of energy. The patient also had fever. The patient inquired if is it normal for the symptoms to come almost two weeks after the injection of the vaccine.
Hair loss starting roughly one to two weeks after first injection.  The hair loss is evenly distributed over my head.  I have probably lost at least 50% of my hair. I continue to shed an unusually large amount of hair daily.
Case number PHEH2014US008651 is an initial spontaneous report received from the nurse on 29 Apr 2014. This report refers to an 11-years-old female child. On 29 Apr 2014, she was vaccinated intramuscularly with only Men A lyophilized component of MENVEO (batch number: A12129) which was reconstituted with sterile water instead of Men CYW-135 liquid component. No adverse event reported following this medication error (wrong solution used in drug reconstitution).
Left arm swelling to shoulder with induration and tenderness. Will follow-up 48-72 hours.
C/O heat & swelling of entire upper arm, radiating to axilla, chills & fever, This began 3-4 hours after injection of PNEUMOVA X, lasting 3 days.
Redness and swelling left arm 5.5x4.75 inches at injection site down left arm. Warm to the touch. Used ice and Tylenol.
Received Pneumococcal Polysaccharide Vaccine on 10/20/04.  It was a shot in the back of my left arm.  Fever and chills began October 21.  Hot red area at the site kept growing larger and stayed hot through 10/23/04 with some fever.  I measured it on 10/23 and it was 9" long traveling down the arm and about 5 1/2" wide.  On 10/24/04 the site started to stop spreading and by 10/26 the color was fading.  It still had a hard lump at the site but is getting better.
Headache, Sedation, Myalgia, Arthralgia & Fever Narrative:   Other Relevant History:
16 hours after fist shot, experienced severe swelling and redness at injection site on left arm. Full 24 hours after injection, full blown swelling, bruising, painful to the touch dark red/ dark purple welt.  36 hours after injection, still dark purple/ red painful welt to the touch. At this time, the welt is warm to the touch and itches throughout the day.  Full week after injection- welt is raised and visible, still dark red/ purple and warm to the touch. Welt is the size of 2 quarters horizontally on my left arm, halfway across  upper arm.
This spontaneous report as received from medical assistant refers to a patient of unknown age and gender. On 24-FEB-2014 the patient was vaccinated with PROQUAD (strength, dose number, dose unit, lot # route unknown) that expired on 21-FEB-2014. No adverse symptoms reported. The outcome of received an expired dose of PROQUAD and no adverse symptoms was unknown. No further information provided. Additional information has been requested.
5/19/04: PC from 155 Nurse to report. Phone call to mom. Parent reports developed local tenderness redness 1-2 days after injection right leg site continued tender and firmness "lump". Mom showed to her doctor approximately 1 week after injection. Doctor not concerned. Eventually site "came to a head like a pimple". Mom "pinched it" and "green pus came out.". It drained 2 weeks approximately on and off small amounts. Mom applied antibiotic ointment. No drainage now x 1 week.
No additional AE; expired dose of ROT ATEQ was administered to a patient on 2/9/2021; This spontaneous report was received from a nurse and refers to a patient of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 09-FEB-2021, the patient was vaccinated with an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot#S012679, expiration date reported as 17-JAN-2021, but upon internal review established as 07-JAN-2021 (formulation, strength, dose, frequency, route of administration, lot # and expiration date were not reported) for prophylaxis. It was a second dose of the series. No additional adverse event was reported.
2 days duration Fever 102 F Chills Crushing fatigue - mostly slept and needed to have help walking my dog  Body aches and random stabbing pains Hip and knee pain Dim vision  All over skin sensitivity  (did not have that last time) No appetite Pain at injection site
Pt recvd 1st dose of Recomb vax on 14JAN91 & on 19JAN91 pt exp dizziness & six days later pt exp night sweats & on 26JAN91 pt exp arthralgia which persisted x 4 days; sx gradually subsided;
Nausea undescribable fatigue! Injection site still painful after a month, fever, chills 1 week. Feels like I have an infection I didn't  have before having the tetanus.
Red, hot to the touch and Swollen  in the vaccination area , a week after the first dose.